🔎 Trials Near Me

Home › Pain After Surgery › NCT05991453

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria

Each patient must meet all of the following criteria:

1. Aged 18 years or older
2. Undergoing elective non-cardiac surgery expected to last ≥ 60 min requiring general anesthesia with a tracheal tube or laryngeal mask airway (or similar supra-glottic device)

Exclusion Criteria

Patients will not be enrolled if any of the following criteria are met:

1. Inability to provide informed consent in English (at all study sites) or Spanish (at sites where Spanish consent is provided as an option)
2. Pregnancy (based on patient report or positive test on the day of surgery)
3. Surgical procedure requiring general, regional, neuraxial anesthesia administered by an anesthesia clinician (anesthesiologist, CRNA, anesthesiology assistant) occurring within 30 days prior to or planned to occur within 30 days after surgery date
4. Contraindication to propofol TIVA or INVA (for example, documented allergy to propofol, history of severe postoperative nausea or vomiting, concern for or history of malignant hyperthermia) based on self-report
5. Surgical procedures requiring a specific general anesthesia technique (for example, TIVA required for neuromonitoring).
6. Locally approved, written protocol mandating a particular anesthetic technique
7. History of possible or definite intraoperative awareness during general anesthesia based on patient self-report
8. Planned postoperative intubation
9. Current incarceration

About the study

The investigators will conduct a 13,000-patient randomized multi-center trial to determine (i) which general anesthesia technique yields superior patient recovery experiences in any of three surgical categories ((a) major inpatient surgery, (b) minor inpatient surgery, (c) outpatient surgery) and (ii) whether TIVA confers no more than a small (0.2 %) increased risk of intraoperative awareness than INVA in patients undergoing both outpatient and inpatient surgeries

What is being tested

Sponsor: Washington University School of Medicine · Participants: 13,000 · Started: Sep 13, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT05991453

Locations in the U.S.

ArkansasUniversity of Arkansas for Medical Sciences (UAMS), Little Rock
CaliforniaUniversity of California San Francisco, San Francisco
Stanford University, Stanford (Not yet recruiting)
ConnecticutYale School of Medicine, New Haven
MarylandJohns Hopkins School of Medicine, Baltimore
MassachusettsBrigham & Women's, Boston
Massachusetts General Hospital, Boston
MichiganUniversity of Michigan, Ann Arbor
Henry Ford Health, Detroit
MissouriWashington University School of Medicine, St Louis
New HampshireDartmouth Hitchcock Medical Center, Lebanon
New YorkNYU Langone, New York
Weill Cornell Medicine, New York
North CarolinaUniversity of North Carolina School of Medicine, Chapel Hill
Duke University, Durham
Wake Forest, Winston-Salem
OregonOregon Health and Sciences University, Portland
PennsylvaniaTemple University, Philadelphia
University of Pennsylvania, Philadelphia (Not yet recruiting)
TexasUniversity of Texas Southwestern, Dallas
University of Texas - MD Anderson, Houston
UtahUniversity of Utah - Medical, Salt Lake City
VirginiaUVA Health, Charlottesville
WashingtonUniversity of Washington, Seattle

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.